PROGRESSIVE RENAL-INSUFFICIENCY IN METHYLMALONIC ACIDEMIA

被引：28

作者：

MOLTENI, KH

OBERLEY, TD

WOLFF, JA

FRIEDMAN, AL

机构：

[1] Department of Pediatrics, University of Wisconsin School of Medicine, Madison, 53792, WI

[2] Department of Pathology, University of Wisconsin School of Medicine, Madison, 53792, WI

来源：

PEDIATRIC NEPHROLOGY | 1991年 / 5卷 / 03期

关键词：

METHYLMALONIC ACIDEMIA; INTERSTITIAL NEPHRITIS; PROTEIN RESTRICTION; RENAL INSUFFICIENCY;

D O I：

10.1007/BF00867492

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Methylmalonic acidemia is a heterogeneous inborn error of propionate metabolism. Therapy frequently includes a low-protein diet to minimize precursors of methylmalonic acid (MMA) and reduce its concentration in body tissues. Renal dysfunction in these patients is increasingly recognized. Tubulointerstitial disease has been found in the small number of renal biopsy specimens from young children previously reported by others. We describe an 18-year-old patient with the mut- form of the disease who developed renal dysfunction despite the use of a low-protein diet. Tubulointerstitial injury was documented by renal biopsy. The patient had no risk factors associated with established causes of chronic tubulointerstitial nephropathy (CTIN). We postulate that methylmalonyl-CoA and/or its precursors (propionyl-CoA, odd-chain fatty acids), may be capable of producing CTIN. We speculate that prevention of renal injury may require lower tissue levels of MMA and its precursors than those required for prevention of ketoacidosis.

引用

页码：323 / 326

页数：4

共 32 条

[1]

Rosenberg L., Fenton W., Beaudet A., Sly W., Valle D., Disorders of propionate and methylmalonate metabolism, The metabolic basis of inherited disease, pp. 821-824, (1989)

[2]

Rosenberg L.E., The inherited methylmalonic acidemias, Prog Clin Biol Res, 103, pp. 187-209, (1982)

[3]

Morrow G., Methylmalonic acidemia, Heritable disorders of amino acid metabolism, pp. 61-80, (1974)

[4]

Walter J.H., Michalski A., Wilson W.M., Leonard J.V., Barrah T.M., Dillon M.J., Chronic renal disease in methylmalonic acidemia, Eur J Pediatr, 148, pp. 344-348, (1989)

[5]

Broyer M., Guesry P., Burgess E.A., Charpentier C., Lemonnier A., Acidemie methyl malonique avec nephropathie hyperuricemique, Arch Fr Pediatr, 31, pp. 543-552, (1974)

[6]

Nyhan W.L., Fawcett N., Ando T., Rennert O.M., Julius R.L., Response to dietary therapy in B<sub>12</sub> unresponsive methylmalonic acidemia, J. Neurogenet, 2, pp. 31-39, (1973)

[7]

Whelan D.T., Ryan E., Spate M., Morris M., Hurley R.M., Hill R., Methylmalonic acidemia: 6 years' clinical experience with two variants unresponsive to vitamin B<sub>12</sub> therapy, Can Med Assoc J, 120, pp. 1230-1235, (1979)

[8]

Lee D.B., Kurokawa K., Physiology of phosphorus metabolism, Clinical disorders of fluid and electrolyte metabolism, pp. 274-279, (1987)

[9]

Jonas A.J., Conley S., Marshall R., Johnson R., Marks M., Rosenberg H., Nephropathic cystinosis with central nervous system involvement, Am J Med, 83, pp. 966-970, (1987)

[10]

Cochat P., Drachman R., Gagnadoux M., Pariente D., Broyer M., Cerebral atrophy in nephropathic cystinosis, Arch Dis Child, 61, pp. 401-403, (1986)

← 1 2 3 4 →